Department of Health Behavior and Health Education, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC 27599-7440, USA.
Sex Transm Dis. 2010 Mar;37(3):197-203. doi: 10.1097/OLQ.0b013e3181bf542c.
Due to higher rates of human papillomavirus (HPV) infection and anal cancer among gay and bisexual men, we aimed to characterize their willingness to get HPV vaccine and identify correlates of vaccine acceptability.
We surveyed a national sample of men aged 18 to 59 who self-identified as either gay (n = 236) or bisexual (n = 70) during January 2009. We analyzed data using multivariate logistic regression.
Most men had heard of HPV vaccine (73%, 224/306) and were willing to get it (74%, 225/306). HPV vaccine acceptability was higher among men who believed their doctor would recommend getting the vaccine (OR = 12.87, 95% CI: 4.63-35.79) and those who were unsure (OR = 3.15, 95% CI: 1.47-6.76), as compared to men who believed their doctor would not recommend it. Acceptability was also higher among men who reported 5 or more lifetime sexual partners (OR = 3.39, 95% CI: 1.34-8.55), perceived greater severity of HPV-related disease (OR = 1.92, 95% CI: 1.18-3.14), perceived higher levels of HPV vaccine effectiveness (OR = 1.97, 95% CI: 1.27-3.06), or reported higher levels of anticipated regret if they did not get vaccinated and later developed an HPV infection (OR = 2.39, 95% CI: 1.57-3.61).
HPV vaccine acceptability was high among gay and bisexual men. These findings identify potentially important beliefs and attitudes for future communication efforts about HPV and HPV vaccine among gay and bisexual men.
由于男同性恋和双性恋男性的人乳头瘤病毒(HPV)感染率和肛门癌发病率较高,我们旨在描述他们接种 HPV 疫苗的意愿,并确定疫苗可接受性的相关因素。
我们在 2009 年 1 月调查了一个自我认同为男同性恋(n=236)或双性恋(n=70)的 18 至 59 岁男性的全国性样本。我们使用多变量逻辑回归分析数据。
大多数男性听说过 HPV 疫苗(73%,224/306),并且愿意接种(74%,225/306)。与认为医生不会推荐接种疫苗的男性相比,相信医生会推荐接种疫苗的男性(OR=12.87,95%CI:4.63-35.79)和不确定的男性(OR=3.15,95%CI:1.47-6.76)HPV 疫苗接受度更高。报告有 5 个或更多性伴侣的男性(OR=3.39,95%CI:1.34-8.55)、认为 HPV 相关疾病更严重的男性(OR=1.92,95%CI:1.18-3.14)、认为 HPV 疫苗有效性更高的男性(OR=1.97,95%CI:1.27-3.06)或报告如果不接种疫苗而后来感染 HPV,他们会感到更高程度的预期遗憾的男性(OR=2.39,95%CI:1.57-3.61),其 HPV 疫苗接受度也更高。
HPV 疫苗在男同性恋和双性恋男性中接受度较高。这些发现确定了未来在男同性恋和双性恋男性中关于 HPV 和 HPV 疫苗的沟通工作中可能重要的信念和态度。